Atrinsic (PTIX) to Release Quarterly Earnings on Monday

Atrinsic (NASDAQ:PTIX) is anticipated to issue its resultson Monday, May 11th. Analysts expect the company to announce earnings of ($4.48) per share for the quarter.

Atrinsic Stock Performance

Shares of PTIX remained flat at $0.80 during midday trading on Monday. The stock had a trading volume of 3,350 shares, compared to its average volume of 44,782. The stock has a market capitalization of $1.45 million, a P/E ratio of -0.10 and a beta of 1.13. The firm has a fifty day moving average of $0.59 and a 200 day moving average of $1.15. Atrinsic has a 12 month low of $0.25 and a 12 month high of $14.28.

Atrinsic Company Profile

Protagenic Therapeutics, Inc, a biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. Its lead compound comprises PT00114, a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. Protagenic Therapeutics, Inc is headquartered in New York, New York.